Patents by Inventor Suntje Sander-Struckmeier

Suntje Sander-Struckmeier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF TO TREAT PANCREATIC ENZYME INSUFFICIENCY
    Publication number: 20200230064
    Abstract: The present disclosure relates to pharmaceutical compositions comprising enzymes or enzyme mixtures having lipolytic and other optional other activities and methods of use thereof to treat exocrine pancreatic insufficiency.
    Type: Application
    Filed: March 18, 2020
    Publication date: July 23, 2020
    Inventors: Jerry A. HALL, Pedro Quintana DIAZ, Shufang LlU, Peter GREGORY, Beate JOHANNWILLE, Suntje SANDER-STRUCKMEIER, Hans-Friedrich KOCH
  • PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF TO TREAT PANCREATIC ENZYME INSUFFICIENCY
    Publication number: 20180028454
    Abstract: The present disclosure relates to pharmaceutical compositions comprising enzymes or enzyme mixtures having lipolytic and other optional other activities and methods of use thereof to treat exocrine pancreatic insufficiency.
    Type: Application
    Filed: February 4, 2016
    Publication date: February 1, 2018
    Inventors: Jerry A. HALL, Pedro Quintana DIAZ, Shufang LlU, Peter GREGORY, Beate JOHANNWILLE, Suntje SANDER-STRUCKMEIER, Hans-Friedrich KOCH
  • Method for the treatment of diabetes
    Patent number: 7122357
    Abstract: The use of physiologically acceptable enzyme mixtures having lipolytic, proteolytica and amylolytic activity, of microbial or animal origin, preferably digestive enzyme mixtures such as pancreatin or digestive enzyme mixtures containing pancreatin, for the treatment of diabetes. The invention also relates to the production of pharmaceutical compositions suitable for such treatment. A preferred variant of the invention relates to use of this enzyme mixture having lipolytic, proteolytic and amylolytic activity, especially digestive enzyme mixtures such as pancreatin or digestive enzyme mixtures containing pancreatin, for the adjuvant treatment of type I or type II diabetes mellitus.
    Type: Grant
    Filed: September 17, 2001
    Date of Patent: October 17, 2006
    Assignee: Solvay Pharmaceuticals GmbH
    Inventors: Suntje Sander-Struckmeier, Claus Rudolf Steinborn, Martin A. Rudmann, Diethard Schwanitz, Friederike Henniges
  • Method for the treatment of diabetes
    Publication number: 20020061302
    Abstract: The use of physiologically acceptable enzyme mixtures having lipolytic, proteolytica and amylolytic activity, of microbial or animal origin, preferably digestive enzyme mixtures such as pancreatin or digestive enzyme mixtures containing pancreatin, for the treatment of diabetes. The invention also relates to the production of pharmaceutical compositions suitable for such treatment. A preferred variant of the invention relates to use of this enzyme mixture having lipolytic, proteolytic and amylolytic activity, especially digestive enzyme mixtures such as pancreatin or digestive enzyme mixtures containing pancreatin, for the adjuvant treatment of type I or type II diabetes mellitus.
    Type: Application
    Filed: September 17, 2001
    Publication date: May 23, 2002
    Inventors: Suntje Sander-Struckmeier, Claus Rudolf Steinborn, Martin A. Rudmann, Diethard Schwanitz, Friederike Henniges